In
its quest to serve humanity RELIANCE
has now made anti-diabetics as a part
of its portfolio. The Company has
launched oral Hypoglycemic agents
to impart the benefit of quality &
economy to diabetic patients. As a
direct step towards innovation, the
Company is relaunching the years old
Molecule Aspirin in the new Form.
The new enteric coated Aspirin, thus
bridging the gap between 400 B.C.
and the 21st Century. |
|
